These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1645826)

  • 1. Serum thymidine kinase in diagnosis and follow-up of the small cell carcinoma of the lung.
    Abbasciano V; Graziano L; Arcudi D; Felisatti G; Cavallini AR; Reali MG; Calia N; Campi S; Guglielmini C
    Med Oncol Tumor Pharmacother; 1991; 8(1):29-34. PubMed ID: 1645826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis.
    Gronowitz JS; Bergström R; Nôu E; Påhlman S; Brodin O; Nilsson S; Källander CF
    Cancer; 1990 Aug; 66(4):722-32. PubMed ID: 2167141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
    Jiang ZF; Wang M; Xu JL
    Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Usefulness of carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA), enolase (NSE) and thymidine-kinase (TK) in the monitoring and prognosis of primary carcinoma of the lung].
    De Angelis G; De Marinis F; Bigioni D; Migliorino MR; Alma MG; Pigorini F
    J Nucl Med Allied Sci; 1990; 34(4 Suppl):135-40. PubMed ID: 1965445
    [No Abstract]   [Full Text] [Related]  

  • 5. [The prescription of serum tumor markers in a general hospital].
    Watine J; Charet JC; Augé MC
    Presse Med; 1998 May; 27(18):862, 864. PubMed ID: 9767874
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum thymidine kinase as a marker of disease activity in patients with multiple myeloma.
    Brown RD; Joshua DE; Ioannidis RA; Kronenberg H
    Aust N Z J Med; 1989 Jun; 19(3):226-32. PubMed ID: 2528340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma antigen as an adjunct tumour marker in primary carcinoma of the lung.
    Cheah PL; Liam CK; Yap SF; Looi LM
    J Clin Pathol; 1994 Jun; 47(6):535-7. PubMed ID: 8063936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer.
    Bergman B; Brezicka FT; Engström CP; Larsson S
    Eur J Cancer; 1993; 29A(2):198-202. PubMed ID: 8380696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen.
    Niho S; Nishiwaki Y; Goto K; Ohmatsu H; Matsumoto T; Hojo F; Ohe Y; Kakinuma R; Kodama T
    Lung Cancer; 2000 Mar; 27(3):159-67. PubMed ID: 10699689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
    Ma L; Xie XW; Wang HY; Ma LY; Wen ZG
    Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An evaluation of carcinoembryonic antigen (CEA), beta 2-microglobulin (BMG), and immunosuppressive acidic protein (IAP) in the serum of primary lung cancer patients].
    Higuchi Y
    Gan No Rinsho; 1986 Jan; 32(1):33-40. PubMed ID: 3005690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum thymidine kinase activity in dogs with malignant lymphoma: a potent marker for prognosis and monitoring the disease.
    von Euler H; Einarsson R; Olsson U; Lagerstedt AS; Eriksson S
    J Vet Intern Med; 2004; 18(5):696-702. PubMed ID: 15515587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cytokeratin fragment 19 (CYFRA 21-1), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma.
    Huang MS; Jong SB; Tsai MS; Lin MS; Chong IW; Lin HC; Hwang JJ
    Respir Med; 1997 Mar; 91(3):135-42. PubMed ID: 9135852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum biomarkers of non-neuron-endocrine origin in small-cell lung cancer: a 16-year study on carcinoembryonic antigen, tissue polypeptide antigen and lactate dehydrogenase.
    Buccheri G; Ferrigno D;
    Lung Cancer; 2000 Oct; 30(1):37-49. PubMed ID: 11008008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of carcinoembryonic antigen (CEA) and brain-type creatine kinase (CK-BB) in serum from patients with carcinoma of the lung.
    Nikliński J; Furman M; Laudański J; Pałynyczko Z; Welk M
    Neoplasma; 1991; 38(2):129-35. PubMed ID: 1645850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Carcinoembryonic antigen and hormonal polypeptides in patients with lung cancer].
    Afrikian MN; Zaĭtseva TI; Bogdasarov IuB
    Med Radiol (Mosk); 1985 Apr; 30(4):7-10. PubMed ID: 2985906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor markers in the diagnosis and follow-up of head and neck cancer: role of CEA, CA 19-9, SCC, TK, and dTTPase.
    Walther EK; Dahlmann N; Gorgulla HT
    Head Neck; 1993; 15(3):230-5. PubMed ID: 8387981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The importance of measuring plasma carcinoembryonic antigen in small-cell anaplastic carcinoma].
    Michetti G; Bamberga M; Pugliese C; Ori Belometti M; Arnone P; Minio A; Ciaravino G; Villa R; Alesina R; Cottini M
    Minerva Med; 1994 May; 85(5):231-6. PubMed ID: 8028751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological thymidine kinase 1 is a prognostic factor in oesophageal, cardial and lung carcinomas.
    Li Z; Wang Y; He J; Ma J; Zhao L; Chen H; Li N; Zhou J; He E; Skog S
    Eur J Cancer Prev; 2010 Jul; 19(4):313-8. PubMed ID: 20479645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum pro-gastrin-releasing peptide is a useful marker for treatment monitoring and survival in small-cell lung cancer.
    Sunaga N; Tsuchiya S; Minato K; Watanabe S; Fueki N; Hoshino H; Makimoto T; Ishihara S; Saito R; Mori M
    Oncology; 1999; 57(2):143-8. PubMed ID: 10461062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.